Literature DB >> 17786302

Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells.

Masanori Yoshino1, Toshiyuki Ishiwata, Masanori Watanabe, Tetsuro Matsunobu, Osamu Komine, Yuri Ono, Tetsushi Yamamoto, Takenori Fujii, Koshi Matsumoto, Akira Tokunaga, Zenya Naito.   

Abstract

The keratinocyte growth factor receptor (KGFR), also known as FGFR2 IIIb, is mainly localized in epithelial cells and is activated by the keratinocyte growth factor (KGF) that is predominantly synthesized by mesenchymal cells. In this study, we examined the roles of KGFR and KGF in human esophageal cancer (EC). In noncancerous esophageal tissues, KGFR was localized in epithelial cells from the basal region of the epithelium to the lower one-third of the epithelium, and KGF was weakly localized in the basal to parabasal epithelial cells. On the other hand, Ki-67 was localized in the parabasal cells. In EC tissues, KGFR and KGF were expressed in cancer cells in 22 and 37 of 54 patients, respectively. The coexpression of KGFR and KGF in cancer cells was detected in 14 of 54 (26%) patients. Clinicopathologically, KGFR expression correlated with the well-differentiated cell type of EC (p<0.001), and KGF expression correlated with lymphatic invasion and lymph node metastasis (p=0.004 and 0.021, respectively). The coexpression of KGFR and KGF in cancer cells correlated with the well-differentiated cell type of EC (p=0.001). KGFR-positive, KGF-positive and KGFR/KGF coexpression patients tended to have shorter survival rates, but the survival rates were not statistically significantly different (p=0.44, 0.059 and 0.112, respectively). In human EC cell lines (TE-1, TE-8 and TE-11), KGFR mRNA was expressed but no KGF mRNA was detected. The KGFR mRNA level was highest in TE-1 cells, derived from well-differentiated SCC and lowest in TE-8 cells. KGFR was detected in the cancer cell lines by Western blot analysis. Recombinant human KGF significantly stimulated the growth of TE-8 and -11 cells, derived from moderately differentiated SCC, but had no effect on TE-1 cell growth. These results suggest that KGFR expression correlates with the differentiation of a normal esophageal epithelium and the well-differentiated cell type of EC. On the other hand, KGF may induce the growth of some EC cells in a paracrine manner and closely correlates with lymphatic invasion and lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786302

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine?

Authors:  Richard R Keld; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

2.  Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.

Authors:  Ken Hatogai; Satoshi Fujii; Takashi Kojima; Hiroyuki Daiko; Shogo Nomura; Toshihiko Doi; Shigehisa Kitano; Atsushi Ohtsu; Yuichi Takiguchi; Takayuki Yoshino; Atsushi Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-29       Impact factor: 4.553

3.  Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro.

Authors:  Andrea Hille; Susanne Grüger; Hans Christiansen; Hendrik A Wolff; Beate Volkmer; Jörg Lehmann; Wolfgang Dörr; Margret Rave-Fränk
Journal:  Radiat Environ Biophys       Date:  2010-03-07       Impact factor: 1.925

4.  Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.

Authors:  Yuanqing Ye; Kenneth K Wang; Jian Gu; Hushan Yang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

5.  Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.

Authors:  Kazumitsu Cho; Yoko Matsuda; Junji Ueda; Eiji Uchida; Zenya Naito; Toshiyuki Ishiwata
Journal:  Int J Oncol       Date:  2011-12-06       Impact factor: 5.650

6.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

7.  Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.

Authors:  Mervi Toriseva; Risto Ala-aho; Sirkku Peltonen; Juha Peltonen; Reidar Grénman; Veli-Matti Kähäri
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.

Authors:  Shin Saito; Kazue Morishima; Takashi Ui; Hiroko Hoshino; Daisuke Matsubara; Shumpei Ishikawa; Hiroyuki Aburatani; Masashi Fukayama; Yoshinori Hosoya; Naohiro Sata; Alan K Lefor; Yoshikazu Yasuda; Toshiro Niki
Journal:  BMC Cancer       Date:  2015-02-25       Impact factor: 4.430

9.  Epithelial expression of keratinocytes growth factor in oral precancer lesions.

Authors:  Sudha Jimson; S Murali; Susan L Zunt; Lawrence I Goldblatt; Mythily Srinivasan
Journal:  Dent Res J (Isfahan)       Date:  2016 May-Jun

10.  Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer.

Authors:  Sara Pinto Teles; Patrícia Oliveira; Marta Ferreira; Joana Carvalho; Pedro Ferreira; Carla Oliveira
Journal:  Cancers (Basel)       Date:  2019-12-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.